Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors

Goedert, 2006, A century of Alzheimer's disease, Science, 314, 777, 10.1126/science.1132814 Alzheimer’s Disease International. World Alzheimer Report 2015: The global impact of dementia: an analysis of prevalence, incidence, costs and trends. London: Alzheimer’s Disease International (ADI); 2015. Available at: https://www. alz.co.uk/research/world-report-2015. Kumar, 2015, A review on Alzheimer’s disease pathophysiology and its management: an update, Pharmacol. Rep., 67, 195, 10.1016/j.pharep.2014.09.004 Berk, 2014, Investigational drugs in Alzheimer’s disease: current progress, Expert Opin. Invest. Drugs, 23, 837, 10.1517/13543784.2014.905542 Gocer, 2015, Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates, J. Enzyme Inhib. Med. Chem., 30, 316, 10.3109/14756366.2014.928704 Ferreiravieira, 2016, Alzheimer's disease: targeting the cholinergic system, Curr. Neuropharmacol., 14 Xie, 2013, Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer’s disease, Eur. J. Med. Chem., 64, 540, 10.1016/j.ejmech.2013.03.051 Hosoi, 2015, Plasma cholinesterase activity in Alzheimer’s disease, Neurodegener. Dis., 15, 188, 10.1159/000381532 Ballard, 2005, Cholinesterases: roles in the brain during health and disease, Curr. Alzheimer Res., 2, 307, 10.2174/1567205054367838 Holzgrabe, 2007, Targeting acetylcholinesterase to treat neurodegeneration, Expert Opin. Ther. Tar., 11, 161, 10.1517/14728222.11.2.161 Greig, 2002, Butyrylcholinesterase: an important new target in Alzheimer’s disease therapy, Int. Psychogeriatr., 14, 77, 10.1017/S1041610203008676 Greig, 2005, Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent, Proc. Natl. Acad. Sci. U S A, 102, 17213, 10.1073/pnas.0508575102 Giacobini, 2003, Cholinergic function and Alzheimer's disease, Int. J. Geriat Psychiatry, 18, S1, 10.1002/gps.935 Zhou, 2019, Rational design of multi-target-directed ligands: strategies and emerging paradigms, J. Med. Chem. Chen, 2017, Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease, RSC Adv., 7, 33851, 10.1039/C7RA04385F Zhu, 2018, Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease, J. Enzyme Inhib. Med. Chem., 33, 496, 10.1080/14756366.2018.1430691 Ellman, 1961, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol., 7, 88, 10.1016/0006-2952(61)90145-9 Pourabdi, 2016, Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BChE and 15-LOX, Eur. J. Med. Chem., 123, 298, 10.1016/j.ejmech.2016.07.043 Xie, 2013, Design synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease, Eur. J. Med. Chem., 64, 540, 10.1016/j.ejmech.2013.03.051 Sussman, 1991, Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein, Science, 253, 872, 10.1126/science.1678899 Bourne Y, Taylor P, Zoran Radi|[cacute, et al. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. Embo Journal, 2014, 22(1):1–12. Liu, 2013, Facile syntheses of disubstituted bis(vinylquinolinium)benzene derivatives as G-quadruplex DNA binders, Tetrahedron, 69, 4922, 10.1016/j.tet.2013.04.045 Xie, 2015, Multifunctional tacrine–trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties, Eur. J. Med. Chem., 93, 42, 10.1016/j.ejmech.2015.01.058 Xu, 2016, Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazol core, Bioorg. Med. Chem., 10.1016/j.bmc.2016.05.056 Cheung, 2012, Structures of human acetylcholinesterase in complex with pharmacologically important ligands, J. Med. Chem., 55, 10282, 10.1021/jm300871x Brus, 2014, Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor, J. Med. Chem., 57, 8167, 10.1021/jm501195e Case, David & Betz, Robin & Cerutti, D.S. & Cheatham, Thomas & Darden, Thomas & Duke, Robert & Giese, T.J. & Gohlke, H & Götz, Andreas & Homeyer, N & Izadi, Saeed & Janowski, Pawel & Kaus, J & Kovalenko, Andriy & Lee, Tai-Sung & LeGrand, S & Li, P & Lin, C & Luchko, Tyler & Kollman, P.A. (2016). Amber 2016, University of California, San Francisco. 10.13140/RG. 2. 2. 27958. 70729. Hornak, 2006, Proteins, 65, 712, 10.1002/prot.21123 Wei, 2003, Parameters for the generalized born model consistent with RESP atomic partial charge assignment protocol, J. Phys. Chem. B, 107, 9071, 10.1021/jp034613k Roe, 2013, PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput., 9, 3084, 10.1021/ct400341p Miller, 2012, MMPBSA. py: An efficient program for end-state free energy calculations, J. Chem. Theory Computat., 8, 3314, 10.1021/ct300418h